ArticleFrontiers in pharmacology2022

The Influence of CYP3A4 Genetic Polymorphism and Proton Pump Inhibitors on Osimertinib Metabolism.

Nanyong Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.